| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/08/1992 | EP0493686A1 Monoclonal antibodies to glycolipid carbohydrate chains |
| 07/08/1992 | EP0493575A1 Rotavirus reassortant vaccine |
| 07/08/1992 | EP0493508A1 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
| 07/08/1992 | EP0493494A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 07/08/1992 | EP0493470A1 Assays and reagents for amyloid deposition |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0187858B1 Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein |
| 07/08/1992 | CN1017349B Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 07/07/1992 | US5128360 Method and agents for inhibiting protein aging |
| 07/07/1992 | US5128319 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/07/1992 | US5128129 Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
| 07/07/1992 | US5128128 Virus vaccine |
| 07/07/1992 | US5128127 Immunization |
| 07/07/1992 | US5128122 Nitrogen compound |
| 07/07/1992 | US5128119 Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| 07/07/1992 | CA1304888C Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies |
| 07/07/1992 | CA1304887C Purification of recombinant hepatitis b surface antigen |
| 07/07/1992 | CA1304681C Stable biologically active fluorochemical emulsions |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
| 07/02/1992 | DE4041045A1 Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen Two-phase systems for the production and presentation of foreign antigen in hybrid live vaccines |
| 07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
| 07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
| 07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
| 07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
| 07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491861A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/01/1992 | EP0491859A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 07/01/1992 | EP0491858A1 Method and useful apparatus for preparing pharmaceutical compositions |
| 07/01/1992 | EP0491851A1 Method for the production of in vitro expanded lymphoid cells for use in adoptive immunotherapy |
| 07/01/1992 | EP0491844A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 07/01/1992 | EP0491833A1 Vaccines |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 06/30/1992 | US5126434 Monoclonal antibody specific for a human macrophage chemotactic factor |
| 06/30/1992 | US5126399 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 06/30/1992 | US5126276 Immunoassay for plurality of samples; noncomtamination |
| 06/30/1992 | US5126264 The RESA and FIRA antigens of plasmodium falciparum |
| 06/30/1992 | US5126250 Alteration of carboxy-terminal amino acid or acids from one or both of antibody heavy chains |
| 06/30/1992 | US5126131 Nonimmunogenic material having few and widely spaced haptens insufficient to trigger immune response but sufficient to inhibit it |
| 06/30/1992 | US5126130 Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/25/1992 | WO1992010591A1 Chimeric chains for receptor-associated signal transduction pathways |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010578A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
| 06/25/1992 | WO1992010514A2 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010210A1 Inhibition of angiogenesis by il-1 |
| 06/25/1992 | WO1992010203A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | WO1992008474A3 Treatment of lung diseases |
| 06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
| 06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098292A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
| 06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
| 06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
| 06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0491125A1 Vaccines against equine herpes viruses and their preparation |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | EP0135541B1 Matrix of antibody-coated dots for determination of antigens |
| 06/24/1992 | CN1062168A Chicken anemia virus vaccine and diagnostic |
| 06/24/1992 | CN1062146A Muramyldipeptide derivatives and influenza vaccine comprising derivatives |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
| 06/23/1992 | US5124439 Detecting, preventing, treating blood clot formation |
| 06/23/1992 | US5124264 Monoclonal antibody recognizing atrial natriuretic polypeptide |
| 06/23/1992 | US5124248 Medical diagnosis; immunoassay |
| 06/23/1992 | US5124153 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 06/23/1992 | US5124148 Method for treating viral diseases with attenuated virus |
| 06/23/1992 | US5124147 Mixture of antagonist to platelet activating factor and antibody |
| 06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/23/1992 | US5124081 Amphiphilic lipid compounds, process for their preparation and their applications especially in cosmetics and dermopharmacy |
| 06/23/1992 | CA1303989C Mammal immunization |
| 06/23/1992 | CA1303988C Eimeria acervulina immunogens |
| 06/23/1992 | CA1303983C Solid phase assay |
| 06/23/1992 | CA1303980C Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies and use therefor |
| 06/22/1992 | WO1992011387A1 Diagnosis for porcine malignant hyperthermia |
| 06/22/1992 | WO1992011290A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | CA2098926A1 Medicaments for the treatment of papillomavirus diseases |
| 06/22/1992 | CA2098922A1 Neuronal cholinergic differentiation factor |
| 06/22/1992 | CA2079702A1 Diagnosis for porcine malignant hyperthermia |
| 06/20/1992 | WO1992011030A1 Use of il-4 to enhance immune response to immunogens in vaccines |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/20/1992 | CA2098726A1 Use of il-4 to enhance immune response to immunogens in vaccines |
| 06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
| 06/19/1992 | CA2057842A1 Human monoclonal antibody |
| 06/18/1992 | WO1992011029A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry |
| 06/18/1992 | CA2098281A1 Suppression of immune responses of oligomeric forms of antigen of controlled chemistry |